xmlns:atom="http://www.w3.org/2005/Atom"
9. The fee for a national application for a marketing authorisation relating to an immunological product, a decentralised application where the United Kingdom is the concerned member State or the mutual recognition of a product authorised in another member State is in accordance with the following table.
Menu | National application for a marketing authorisation(£) | Decentralised application where the UK is a concerned member State or recognition of a product authorised in another member State (£) |
---|---|---|
1. Immunological product other than in paragraph 2: Base fee: | 11,775 | 5,785 |
The following fees are in addition to the base fee. | ||
| 7,405 | 2,490 |
| 1,345 | 675 |
| 1,350 | 405 |
| 5,380 | 1,615 |
| 5,380 | 1,615 |
| 2,895 | 1,685 |
2. Immunological product that is identical to a product already authorised in the United Kingdom but with a lesser number of antigens and that only contains antigens contained in that product | 10,430 | 5,380 |